Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HRS-1738
- Development stage
- Phase 2
- Lead developer
- Hengrui Pharmaceutical
- Modality
- Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
HRS-1738 is a class 1 innovative chemical, developed as a **radioactive in vivo diagnostic drug** suitable for **positron emission tomography (PET) imaging** of prostate-specific membrane antigen (PSMA)-positive lesions in patients with prostate cancer[7][9][4][5]. It is administered by injection and provides enhanced diagnostic imaging for prostate cancer. No similar diagnostic product has been approved for marketing domestically or internationally. HRS-1738 is developed by Jiangsu Hengrui Pharmaceuticals and its subsidiary Tianjin Hengrui Pharmaceuticals, with approximately 7.73 million yuan invested in R&D[7][9].
- Brand names
- HRS-1738HRS1738HRS 1738
- Other names
- HRS-1738HRS1738HRS 1738
02
Targets
PSMA (Prostate-specific membrane antigen)
Beyond the preview
Go deeper on HRS-1738.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HRS-1738.